Iconovo

Research Iconovo (ICO) on Bullrun: market cap SEK 108.19M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerICO
• ExchangeST
• CountrySweden
• SectorHealthcare
• IndustryMedical Devices
• CurrencySEK
• Market capSEK 108.19M
• Financial periodQ4 2025
• RevenueSEK 504.00K
• Net income-SEK 12.97M
• Free cash flow-SEK 11.10M
• Gross margin486.7%

Valuation Snapshot

latest market cap is SEK 108.19M.

About Iconovo

Iconovo AB (publ) develops inhaled medicinal products in Sweden. The company offers ICOres, a multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler; and ICOone nasal single-dose dry powder inhaler for nasal use. It serves generic companies. The company has a collaboration agreement with Lonza to develop spray-dried formulations of an intranasal biologic drug;

Frequently asked questions

What is Iconovo's market cap?

Iconovo's market capitalization is SEK 108.19M.

What does Iconovo do?

Iconovo AB (publ) develops inhaled medicinal products in Sweden. The company offers ICOres, a multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler;